Adaptive Biotechnologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.

CEO

Chad Robins

CEOChad Robins

Employees

709

Employees709

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2009

Founded2009

Employees

709

Employees709

ADPT Key Statistics

Market cap

422.22M

Market cap422.22M

Price-Earnings ratio

-1.87

Price-Earnings ratio-1.87

Dividend yield

—

Dividend yield—

Average volume

2.26M

Average volume2.26M

High today

$3.11

High today$3.11

Low today

$2.88

Low today$2.88

Open price

$3.02

Open price$3.02

Volume

2.80M

Volume2.80M

52 Week high

$9.08

52 Week high$9.08

52 Week low

$2.53

52 Week low$2.53

ADPT News

TipRanks 6d

Adaptive Biotechnologies Names Kyle Piskel New CFO - TipRanks.com - TipRanks

Adaptive Biotechnologies Corp (ADPT) has issued an update. Adaptive Biotechnologies Corporation has appointed Kyle Piskel as its new Chief Financial Officer, e...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell